BibTeX
CSL-JSON
MLA
Harvard
Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
release_qq5bh74pp5f3tp5iwxvyvmyiue
by
Nikolay I. Nikolov,
Vladislav R. Dunev,
Angel A. Anatoliev,
Nikolay H. Kolev,
Martin B. Stoykov,
Boyan S. Atanasov
Published
in Journal of Biomedical and Clinical Research
by Walter de Gruyter GmbH.
2022 Volume 15, p70-73
Abstract
<jats:title>Summary</jats:title>
Bladder cancer is a heterogeneous disease in molecular, histological and clinical aspects. Treatment should also be considered from different angles - surgery, intravesical chemo- or immunotherapy, radiation therapy and lifestyle changes. Intravesical treatment of superficial bladder cancer with Еpirubicin or Bacillus Calmette-Guérin (BCG) is a continuation of surgical treatment to reduce or eliminate further recurrence.
In application/xml+jats format
Archived Files and Locations
application/pdf
514.6 kB
file_tyg2gg7dcrcwxerp7bylxqelwu
|
www.sciendo.com (publisher) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Journal Metadata
Open Access Publication
Not in DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
Open Access Publication
Not in DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:
1313-6917
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar